Meridian Bioscience calls all $1.8 million 7% convertible subordinated debentures

By Jennifer Chiou

New York, June 14 - Meridian Bioscience, Inc. announced the redemption of all its outstanding $1.8 million 7% convertible subordinated debentures due Sept. 1, 2006 at par plus accrued interest to July 8.

Prior to the close of business July 7, holders may convert their debentures into shares of Meridian Bioscience common stock at a conversion price of $16.09 per share.

U.S. Bank, NA is trustee and paying agent (800 934-6802).

The Cincinnati, Ohio-based life science company's stock closed Monday at $19.96.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.